Document is current
Any future updates will be listed below
-
Authors
Guo, Xiaonan
Kong, Lingzhuo
Wen, Yalan
Chen, Lizichen
Hu, Shaohua
-
Funding
Funding for this research was provided by:
the Zhejiang Provincial Key Research and Development Program (2021C03107)
the Leading Talent of Scientific and Technological Innovation - "Ten Thousand Talents Program" of Zhejiang Province (2021R52016)
the Innovation team for precision diagnosis and treatment of major brain diseases (2020R01001)
the Fundamental Research Funds for the Central Universities (226-2022-00193, 226-2022-00002)
- License Information
-
More Information
Article History
Received: 4 November 2023
Accepted: 4 October 2024
First Online: 16 October 2024
Declarations
:
: This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (ITT20240569A).
: The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication.
: Due to the retrospective, non-interventional, and anonymous nature of this study, written informed consent from patients was waived.
: Not applicable.
: No animals were used for studies that are the basis of this research. All human procedures followed were in accordance with the Helsinki Declaration of 1975.
: Not applicable since this is a retrospective study rather a clinical trial.
: The authors declare no competing interests.
